DK

Dilip Kumar Ghosh

Active Director Director DIN 08618597
DIN 08618597 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Dilip Kumar Ghosh

Data last updated:

Dilip Kumar Ghosh is a Director at Cadlay Pharma Private Limited (since 2019). The company operates in Pharma. Cadlay Pharma Private Limited reported revenue of ₹3.27 Cr (FY 2024).

DIN 08618597
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2019
Oldest Company Age 6 yrs
Largest company Cadlay Pharma Private Limited · ₹3.27 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cadlay Pharma Private Limited U74999HP2019PTC007708
Director21 Nov 20192019₹3.27 Cr (FY 2024)Active

Board colleagues of Dilip Kumar Ghosh

Directorship timeline

Open interactive timeline →
Cadlay Pharma Private Limited
Premium access

Shareholding and investment profile for Dilip Kumar Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Kumar Ghosh

Dilip Kumar Ghosh currently holds 1 directorship: Cadlay Pharma Private Limited (Director, since 21 Nov 2019, revenue ₹3.27 Cr (FY 2024)).

Dilip Kumar Ghosh was first appointed on 21 Nov 2019 as Director at Cadlay Pharma Private Limited.

The current boards of Dilip Kumar Ghosh's companies include Chitra Sharma (Cadlay Pharma Private Limited), Sanjeev Kumar Sharma (Cadlay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available